Zhengye Biotechnology Holding Limited
Health
Performance
8.0
Risk
Sell
Buy
Curious about the Scores? Learn more.

Zhengye Biotechnology Holding Limited stock rating and score history

All changes in ratings, performance and outlook tracked over time.

25.11.2025
Rock bottom. The fall’s complete, stability nowhere to be found.
29.09.2025
Momentum tanked. Clearly underperforming.
04.09.2025
Trouble brewing. Volatility and pressure rising.
20.08.2025
Pulse detected. Still fragile, but stabilizing.

Zhengye Biotechnology Holding Limited stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Zhengye Biotechnology Holding Limited do? Business model and key facts

Get the full picture of Zhengye Biotechnology Holding Limited: what it builds, where it operates, and how it makes money.

Zhengye Biotechnology Holding Limited Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 278

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

shop
Company facts
Songlin Song
CEO
278
Employees worldwide
shop
Performance
-77.28%
Last 12 months
shop
Growth
$186,36M
Revenue year
$13,47M
Net income
shop
Valuation
$48,34M
Market Cap
0.00
Price/Earnings Ratio

Stocks related to Zhengye Biotechnology Holding Limited

Selected based on industry alignment and relative market positioning.

OGI
Organigram Global Inc.
1.65
+3.13%
7.6
Sell
Buy
Organigram Global Inc.
OGI.TO
OrganiGram Holdings Inc.
2.23
+1.83%
7.8
Sell
Buy
OrganiGram Holdings Inc.
EOLS
Evolus, Inc.
4.95
+2.70%
8.5
Sell
Buy
Evolus, Inc.

Zhengye Biotechnology Holding Limited fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.